{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:42:59Z","timestamp":1790185379868,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ucl.2025.09.003","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:53:18Z","timestamp":1761220398000},"page":"45-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prostate Cancer Grading"],"prefix":"10.1016","volume":"53","author":[{"given":"John","family":"Hanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennady","family":"Bratslavsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksandr","family":"Kravtsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ucl.2025.09.003_bib1","first-page":"125","article-title":"Classification of prostatic carcinomas","volume":"50","author":"Gleason","year":"1966","journal-title":"Cancer Chemother Rep"},{"issue":"9","key":"10.1016\/j.ucl.2025.09.003_bib2","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","article-title":"The 2005 International society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma","volume":"29","author":"Epstein","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.003_bib3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","article-title":"A contemporary prostate cancer grading system: a validated alternative to the gleason score","volume":"69","author":"Epstein","year":"2016","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.ucl.2025.09.003_bib4","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/PAS.0000000000000714","article-title":"Interobserver reproducibility of percent gleason pattern 4 in prostatic adenocarcinoma on prostate biopsies","volume":"40","author":"Sadimin","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.003_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/his.12976","article-title":"Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists","volume":"69","author":"Kweldam","year":"2016","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.003_bib6","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41597-024-03696-0","article-title":"Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkers","volume":"11","author":"Logan","year":"2024","journal-title":"Sci Data"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.003_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/PAS.0000000000000563","article-title":"Prostate cancer grading: a contemporary photomontage","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.003_bib8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4103\/aja202440","article-title":"Histopathological evaluation and grading for prostate cancer: current issues and crucial aspects","volume":"26","author":"Agosti","year":"2024","journal-title":"Asian J Androl"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.003_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-3-319-42740-9_6","article-title":"Intraductal carcinoma of prostate (IDC-P): from obscure to significant","volume":"28","author":"Chen","year":"2016","journal-title":"Chin J Cancer Res"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.003_bib10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.eururo.2024.02.017","article-title":"How to report the minor component of a high-grade pattern in radical prostatectomy specimens: time to abandon the \"tertiary\" terminology?","volume":"86","author":"Cimadamore","year":"2024","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.003_bib11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1586\/14737140.2016.1160780","article-title":"Prostate cancer: from Gleason scoring to prognostic grade grouping","volume":"16","author":"Montironi","year":"2016","journal-title":"Expert Rev Anticancer Ther"},{"issue":"8","key":"10.1016\/j.ucl.2025.09.003_bib12","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International society of urological pathology (ISUP) consensus conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.003_bib13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5858\/arpa.2020-0015-RA","article-title":"The 2019 genitourinary pathology society (GUPS) white paper on contemporary grading of prostate cancer","volume":"145","author":"Epstein","year":"2020","journal-title":"Arch Pathol Lab Med"},{"issue":"21","key":"10.1016\/j.ucl.2025.09.003_bib14","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.3390\/cancers13215378","article-title":"Significant inter- and intralaboratory variation in gleason grading of prostate cancer: a nationwide study of 35,258 patients in The Netherlands","volume":"13","author":"Flach","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.003_bib15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/his.14867","article-title":"Interobserver reproducibility of cribriform cancer in prostate needle biopsies and validation of International Society of Urological Pathology criteria","volume":"82","author":"Egevad","year":"2023","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.003_bib16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00428-020-02902-9","article-title":"Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome","volume":"478","author":"van der Slot","year":"2021","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.003_bib17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/hupa.2001.21134","article-title":"Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists","volume":"32","author":"Allsbrook","year":"2001","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.003_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/hupa.2001.21135","article-title":"Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist","volume":"32","author":"Allsbrook","year":"2001","journal-title":"Hum Pathol"},{"issue":"8","key":"10.1016\/j.ucl.2025.09.003_bib19","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/s41379-021-00794-x","article-title":"An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy","volume":"34","author":"Perincheri","year":"2021","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.ucl.2025.09.003_bib20","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/PAS.0000000000000457","article-title":"Diagnosis of \u201cpoorly formed glands\u201d Gleason pattern 4 prostatic adenocarcinoma on needle biopsy: an interobserver reproducibility study among urologic pathologists with recommendations","volume":"39","author":"Zhou","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.ucl.2025.09.003_bib21","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/PAS.0000000000000235","article-title":"Gleason score 3 + 4=7 prostate cancer with minimal quantity of gleason pattern 4 on needle biopsy is associated with low-risk tumor in radical prostatectomy specimen","volume":"38","author":"Huang","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ucl.2025.09.003_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.anndiagpath.2015.10.013","article-title":"Outcomes of Gleason score 3 + 4 = 7 prostate cancer with minimal amounts (<6%) vs \u22656% of Gleason pattern 4 tissue in needle biopsy specimens","volume":"20","author":"K\u0131r","year":"2016","journal-title":"Ann Diagn Pathol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.003_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.juro.2016.07.076","article-title":"Limitations in predicting organ confined prostate cancer in patients with Gleason pattern 4 on biopsy: implications for active surveillance","volume":"197","author":"Perlis","year":"2017","journal-title":"J Urol"},{"issue":"10","key":"10.1016\/j.ucl.2025.09.003_bib24","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/PAS.0000000000000691","article-title":"Prognostic significance of percentage and architectural types of contemporary Gleason pattern 4 prostate cancer in radical prostatectomy","volume":"40","author":"Choy","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.003_bib25","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.eururo.2015.10.029","article-title":"Clinical utility of quantitative gleason grading in prostate biopsies and prostatectomy specimens","volume":"69","author":"Sauter","year":"2016","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ucl.2025.09.003_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/JU.0000000000002685","article-title":"Oncologic outcomes of total length gleason pattern 4 on biopsy in men with grade group 2 prostate cancer","volume":"208","author":"Perera","year":"2022","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.003_bib27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1309\/AJCPZ7WBU9YXSJPE","article-title":"Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome","volume":"136","author":"Iczkowski","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.003_bib28","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/pros.22786","article-title":"Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens","volume":"74","author":"Kimura","year":"2014","journal-title":"Prostate"},{"issue":"10","key":"10.1016\/j.ucl.2025.09.003_bib29","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.prp.2014.06.002","article-title":"The association of the cribriform pattern with outcome for prostatic adenocarcinomas","volume":"210","author":"Kir","year":"2014","journal-title":"Pathol Res Pract"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.003_bib30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/modpathol.2014.116","article-title":"Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer","volume":"28","author":"Kweldam","year":"2015","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.ucl.2025.09.003_bib31","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/s41379-020-0507-2","article-title":"Clinicopathological characteristics of glomeruloid architecture in prostate cancer","volume":"33","author":"Hollemans","year":"2020","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.ucl.2025.09.003_bib32","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41379-019-0221-0","article-title":"Three-dimensional analysis reveals two major architectural subgroups of prostate cancer growth patterns","volume":"32","author":"Verhoef","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ucl.2025.09.003_bib33","article-title":"Correlation of large cribriform carcinoma and \"unfavorable histology\" with other Gleason pattern 4 subtypes: a proof-of-principle study evaluating 485 radical prostatectomy specimens with proposal for the concept of \"borderline histology\"","volume":"75","author":"Nguyen","year":"2024","journal-title":"Ann Diagn Pathol"},{"issue":"9","key":"10.1016\/j.ucl.2025.09.003_bib34","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.ejca.2014.03.009","article-title":"Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort","volume":"50","author":"Trudel","year":"2014","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.003_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41379-018-0157-9","article-title":"Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis","volume":"32","author":"Hollemans","year":"2019","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.003_bib36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00428-015-1809-5","article-title":"Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy","volume":"467","author":"Keefe","year":"2015","journal-title":"Virchows Arch"},{"issue":"7","key":"10.1016\/j.ucl.2025.09.003_bib37","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/his.14658","article-title":"Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies","volume":"80","author":"Rijstenberg","year":"2022","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.003_bib38","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/his.15102","article-title":"Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer","volume":"84","author":"Greenland","year":"2024","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.ucl.2025.09.003_bib39","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/his.14179","article-title":"Intraductal carcinoma has a minimal impact on grade group assignment in prostate cancer biopsy and radical prostatectomy specimens","volume":"77","author":"Rijstenberg","year":"2020","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.003_bib40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/his.14132","article-title":"Grading of prostate cancer: the impact of including intraductal carcinoma on the overall Grade Group assigned in diagnostic biopsies","volume":"77","author":"Chen-Maxwell","year":"2020","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.ucl.2025.09.003_bib41","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/modpathol.3800702","article-title":"Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance","volume":"19","author":"Guo","year":"2006","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.ucl.2025.09.003_bib42","first-page":"41","article-title":"Prostate pathology: what is new in the 2022 WHO classification of urinary and male genital tumors?","volume":"115","author":"Surintrspanont","year":"2022","journal-title":"Pathologica"},{"issue":"6","key":"10.1016\/j.ucl.2025.09.003_bib43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.anndiagpath.2014.08.010","article-title":"Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists","volume":"18","author":"Iczkowski","year":"2014","journal-title":"Ann Diagn Pathol"},{"issue":"3","key":"10.1016\/j.ucl.2025.09.003_bib44","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/his.13878","article-title":"Atypical intraductal proliferation detected in prostate needle biopsy is a marker of unsampled intraductal carcinoma and other adverse pathological features: a prospective clinicopathological study of 62 cases with emphasis on pathological outcomes","volume":"75","author":"Shah","year":"2019","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.ucl.2025.09.003_bib45","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/his.13273","article-title":"Atypical intraductal proliferation and intraductal carcinoma of the prostate on core needle biopsy: a comparative clinicopathological and molecular study with a proposal to expand the morphological spectrum of intraductal carcinoma","volume":"71","author":"Shah","year":"2017","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.ucl.2025.09.003_bib46","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/PAS.0000000000000794","article-title":"Atypical Intraductal cribriform proliferations of the prostate exhibit similar molecular and clinicopathologic characteristics as intraductal carcinoma of the prostate","volume":"41","author":"Hickman","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.ucl.2025.09.003_bib47","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.euf.2020.10.007","article-title":"Intraductal carcinoma of the prostate: pathogenesis and molecular perspectives","volume":"7","author":"Zong","year":"2021","journal-title":"European Urology Focus"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014325000862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014325000862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:05:40Z","timestamp":1765289140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014325000862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0094014325000862"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2025.09.003","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate Cancer Grading","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2025.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}